Basic Science of Depression and Anxiety (Suss) - 10/13/16 Flashcards
Areas involved in mood disorders
Hippocampus and prefrontal cortex:
- Cognitive abnormalities: memory impairments, hopelessness, worthlessness, guilt
Amygdala
- Anxiety and fear
- Dysphoric emotions
Nucleus acumbens:
- Anhedonia
- Decreased motivation
Hypothalamus
- Neurovegetative symptoms (sleep, appetite, etc…)
Anatomical Observations in Depression
- Enlarged ventricles
- Increased CSF
- Periventricular hyperintensity
- Reduced volume in limbic structures:
- Caudate and basal ganglia
- Hippocampus
- Frontal cortex
- Gyrus rectus
Anatomical risk factor for MDD
Thinner right lateral cortex
(Thinning of right cortex is not associated with MDD but puts you at risk)
- Right: attention, visuospatial memory
Current MDD/anxiety DOES correlate with thinner left medial cortex
Thicker in ORBITOFRONTAL and SUBGENUAL cortex
Neuronal activity correlates for depression
What structures are activated and what structures are deactivated?
Activated:
- areas mediating emotional and stress response (thalamus, amygdala, and orbital and medial prefrontal cortex including subgenual cingulate cortex Cg25)
Deactivated:
- areas implicated in attention and sensory processing (anterior cingulate cortex)
Anatomical observations in PTSD: Cause or Effect?
Smaller hippocampal volume
Smaller pregenual anterior cingulate cortex volume
Smaller hippocampal volume may predispose TO PTSD (regardless of exposure to combat)
Smaller pregenual anterior cingulate cortex volume may result FROM PTSD
Neuronal activity in patients with Obsessive Compulsive Disorder
Hyperactivity observed in:
- Head of caudate
- Anterior cingulate gyrus
- Orbitofrontal cortex
Hyperactivity can be reduced in one of two ways:
- SSRIs
- CBT
OCD relates to Tourette’s and Huntingdon’s Disease
Same pathways affected resulting in hyperactivity of motor function (frontal cortex)
PANDAS
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Strep
Strep: body launches autoimmune attack against stretococcal bacteria and instead of attacking the bacteria, it attacks basal ganglia
Neuronal activity correlates for Panic Disorder
GABA receptors
Panic disorder patient has fewer GABA receptors (red) –> increased activity
GABA - normally inhibitory
Less GABA receptors means more hyperactivity
Hypotheses for Depression:
1. Monoamine Hypothesis
- Hypothalamic Pituitary Adrenal (HPA) Axis Hypothesis
Depression results from decreased availability of either 5-HT (raphe nuclei) or NE (locus coeruleus) or both
Metabolic levels are detected in CSF, plasma and urine:
- Depression: decreased 5-HT, dopamine, and NE
- Mania: increased dopamine
- Anxiety: decreased GABA, increased NE, altered 5-HT
Current Anti-Depressant Drugs
Role of MAO inhibitors
Role of TCAs, SSRIs, SNRIs
MAOIs: prevent degradation of serotonin and NE so that more is around to act on receptor
TCAs, SSRIs, SNRIs: prevent re-uptake of serotonin or NE into presynaptic terminals
3 major caveats to monoamine hypothesis
- 30-46% of patients = treatment resistant
- Increased monoamine transmission can strengthen memory of aversive life event
- Long delay of efficacy
- Desensitization of presynaptic 5-HT inhibitor autoreceptors
- Neuronal adaptation:
- Gene expression
- Neurogenesis
- Synaptogenesis
- Survival
Hypotheses for Depression:
- Monoamine Hypothesis
2. Hypothalamic Pituitary Adrenal (HPA) Axis Hypothesis
Problems in glucocorticoid release feedback mechanism cause mood disorders
Normally, glucocorticoids feedback at multiple levels of pathway (negative feedback)
In depressed patients, either don’t have glucocorticoid receptors OR receptors are not functioning properly so there is continuous release of more glucocorticoid
Hippocampus: negatively inhibits pathway
- If you have small hippocampus, will get less (-) feedback
Amygdala: activates pathway
- Hyperactivity
Result: hitting this pathway on many different levels
Hypotheses for Depression:
- Monoamine Hypothesis
- Hypothalamic Pituitary Adrenal (HPA) Axis Hypothesis
3. Neurotrophin Hypothesis
Neurotrophins = growth factors in brain
Brain-Derived Neurotrophic Factor (BDNF) mediate neuroanatomical changes during stress and antidepressant treatment
- Enhance dendritic branching
- Enhance synapse number
Depressed patients w/o treatment:
Unchecked glucocorticoid regulation → low levels BDNF
- High levels of cortisol
- Patients fail dexamethasone feedback test
Depressed patients w/ treatment:
Monoamines inc levels of BDNF
Neurogenesis - required for antidepressant action
Lack of neurogenesis → depression-like behavior
Factors that enhance and inhibit neurogenesis
Enhance:
- Neurotrophins and neuropeptides
- Antidepressants (inc. expression of glucocorticoid receptors so that feedback mech can be reactivated)
- Deep Brain Stimulation
- Running
- Seizures
- Learning
Inhibit:
- Stress
- Drugs of abuse